Thrombin functions as an inflammatory mediator through activation of its receptor

Journal of Experimental Medicine

Volumn 183, Issue 3, 1996, Pages 821-827

  Cirino, Giuseppe ^a   Cicala, Carla ^a   Bucci, M Rosaria ^a   Sorrentino, Ludovico ^a   Maraganore, John M ^b   Stone, Stuart R ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b BIOGEN   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBIN;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; BLOOD VESSEL PERMEABILITY; BLOOD VESSEL REACTIVITY; ENZYME INHIBITION; HEMOSTASIS; IMMUNE RESPONSE; MAST CELL DEGRANULATION; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION; THROMBOSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTITHROMBINS; CARRAGEENAN; CYTOPLASMIC GRANULES; EDEMA; HIRUDINS; HISTAMINE; INFLAMMATION; MALE; MAST CELLS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, THROMBIN; RECOMBINANT PROTEINS; SEROTONIN; THROMBIN;

EID: 0029862685     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.3.821     Document Type: Article

References (38)

1. Harker, L.A. 1994. New antithrombotic strategies for resistant thrombotic processes. J. Clin. Pharmacol. 34:3-16.
2. Austyn, J.M., and K.J. Wood. 1993. Principles of Cellular and Molecular Immunology. Oxford University Press, Eynsham, Oxon., UK. 499-580.
3. Menkin, V. 1933. Fixation mechanism in sterile inflammation. Proc. Soc. Exp. Biol. Med. 30:1069-1078.
4. Movat, H.Z., R.H. More, and D. Wolochow. 1960. Cellular and intercellular changes after mechanical, chemical, or radiation injury of connective tissue. Br. J. Exp Pathol. 41:97-106.
5. Razin, E., and G. Marx. 1984. Thrombin-induced degranulation of cultured bone marrow-derived mast cells. J. Immunol 133:3282-3285.
6. Jones, A., and C.L. Geczy. 1990. Thrombin and factor Xa enhance the production of interleukin-1. Immunology. 71: 236-241.
7. Malik, A.B., and J.W. Fenton II. 1992. Thrombin-mediated increase in vascular endothelial permeability. Semin. Thromb. Hemostasis. 18:193-199.
8. Moser, R., P. Groscurth, and J. Fehr. 1990. Promotion of transendothehal neutrophil passage by human thrombin. J. Cell Sci. 96:737-744.
9. Toothill, V.J., J.A. Van Mourik, H.K. Niewenhuis, M.J. Metzelaar, and J.D. Pearson. 1990. Characterization of the enhanced adhesion of neutrophil leukocytes to thrombin-stimulated endothelial cells. J. Immunol. 145:283-291.
10. Lorant, D.E., K.D. Patel, T.M. McIntyre, R.P. McEver, S.M. Prescott, and G.A. Zimmerman. 1991. Coexpression of GMP-140 and PAF by endothehum stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J. Cell Biol. 115:223-234.
11. Sugama, Y., C. Tiruppathi, K. Janakidevi, T.T. Andersen, J.W. Fenton II, and A.B. Malik. 1992. Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion. J. Cell Biol. 119:935-944.
12. Bizios, R., L. Lai, J.W. Fenton II, and A.B. Malik. 1986. Thrombin-induced chemotaxis and aggregation of neutrophils. J. Cell. Physiol. 120:485-490.
13. Rowand, J.K., P. Marucha, and L.J. Berliner. 1992. Hirudin C-terminal fragments inhibit thrombin induced neutrophil chemotaxis. Thromb. Haemostasis. 67:289-291.
14. Vu, T.K., D.T. Hung, V.I. Wheaton, and S.R. Coughlin. 1991. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 64:1057-1068.
15. Pinheiro, J.M., T.T. Andersen, and A.B. Malik. 1993. Receptor mechanism of thrombin-mediated pulmonary vasodilation in neonates. Am. J. Physiol. 265:L355-359.
16. 2+ mobilization, barrier dysfunction, prostaglandin synthesis, and platelet-derived growth factor mRNA expression in cultured endothelium. J. Cell. Physiol. 156:541-549.
17. Edwards, R.L., and F.R. Rickles. 1992. The role of leukocytes in the activation of blood coagulation. Semin. Hematol. 29:202-212.
18. Maraganore, J.M., P. Bourdon, J. Jablonski, K.L. Ramachandran, and J.W. Fenton II. 1990. Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin. Biochemistry. 29:7095-7101.
19. Chao, B.H., S. Kalkunte, J.M. Maraganore, and S.R. Stone. 1992. Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor. Biochemistry. 31:6175-6178.
20. Di Rosa, M., J.P. Giroud, and D.A. Willoughby. 1971. Studies of the mediators of the acute inflammatory response induced in rats at different sites by carrageenan and turpentine. J. Pathol. 104:15-29.
21. Antunes, E., M. Manano, G. Cirino, S. Levi, and G. de Nucci. 1990. Pharmacological characterization of polycation-induced rat hind paw oedema. Br. J. Pharmacol. 101:986-990.
22. Williams, T.J. 1973. Prostaglandin E2, prostaglandin 12 and the vascular changes in inflammation. Br. J. Phamacol. 65: 517-524.
23. Brain, S.D., and T.J. Williams. 1985. Inflammatory oedema induced by calcitonin gene related peptide (CGRP) and mediators of increased vascular permeability. Br. J. Pharmacol. 86: 855-860.
24. Skrzypczak-Jankun, E., V.E. Carperos, K.G. Ravichandran, A. Tulinsky, M. Westbrook, and J.M. Maraganore. 1991. Structure of the hirugen and hirulog 1 complexes of α-thrombin. J. Mol. Biol. 221:1379-1393.
25. Scarborough, R.M., M.A. Naughton, W. Teng, D.T. Hung, J. Rose, T.K. Vu, V.I. Wheaton, C.W. Turck, and S.R. Coughlin. 1992. Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J. Biol. Chem. 267:13146-13149.
26. Mailing, H.M., M.E. Webster, M.A. Williams, W. Saul, and W. Sanderson. 1974. Inflammation induced by histamine. serotonm, bradykinin and compound 40/80 in the rat: antagonists and mechanisms of action. J. Pharmacol. Exp. Ther. 191: 300-310.
27. Damas, J., and G. Remacle-Volon. 1986. Mast cell amines and the oedema induced by zymosan and carrageenans in rats. Eur. J. Phamacol. 121:367-376.
28. Weksler, B.B. 1984. Prostaglandins and vascular function. Circulation. 70:63-71.
29. Sedgwick, A.D., and D.A. Willoughby. 1989. Animal models for testing drugs on inflammatory and hypersensitivity reactions. In Textbook of Immunopharmacology. M.M. Dale and J.C. Foreman, editors. Blackwell Scientific Publications Ltd., London. 253-261.
30. De Clerck, F., Y. Somers, L. Van Gorp, and B. Xhonneux. 1983. Platelet activation by endogenous 5-hydroxytryptamine and histamine released by mast-cell degranulation with compound 48/80 in the rat. Agents Actions. 13:81-87.
31. Cuevas, P. 1986. Lack of effect of compound 48/80 on human umbilical vein endothelium. Anat. Embryol. 175:163-166.
32. Gaboury, J.P., B. Johnston, X.F. Niu, and P. Kubes. 1995. Mechanisms underlying acute mast cell-induced leukocyte rolling and adhesion in-vivo. J. Immunol. 154:804-813.
33. Beer, D.J., and R.E. Rocklin. 1987. Histamine and modulation of lymphocyte biology: membrane receptors, signal transmission and functions. Crit. Rev. Immunol. 7:55-91.
34. Coller, B.S., P. Ward, M. Ceruso, L.E. Scudder, K. Springer, J. Kutok, and G.D. Prestwich. 1992. Thrombin receptor activating peptides - importance of the N-terminal serine and its ionization state as judged by pH dependence, nuclear magnetic resonance spectroscopy, and cleavage by aminopeptidase-M. Biochemistry. 31:11713-11720.
35. Jenkins, A.L., G.L. Howells, E. Scott, B.F. Le Bonniec, M.A. Curtis, and S.R. Stone. The response to thrombin of human neutrophils. Evidence for two novel receptors. J. Cell Sci. In press.
36. Colotta, F., F.L. Sciacca, M. Sironi, W. Lumi, M.J. Rabiet, and A. Mantovani. 1994. Expression of monocyte chemotaccic protein-1 by monocytes and endothelial cells exposed to thrombin. Am. J. Pathol. 144:975-985.
37. Grandaliano, G., A.J. Valente, and H.E. Abboud. 1994. A novel biologic activity of thrombin: stimulation of monocyte chemotactic protein production. J. Exp. Med. 179:1737-1741.
38. Bar Shavit, R., A. Kahn, G.D. Wilner, and J.W. Fenton II. 1983. Monocyte chemotaxis: stimulation by specific exosite region in thrombin. Science (Wash. DC). 220:728-731.